I have run thru most of Favipiravir occurrence on US
I have run thru most of Favipiravir occurrence on US clinicaltrials.gov looking for intravenous use in covid and even non-covid.
I've seen nothing related to Favipiravir given intravenously in any of these many trials. It's all oral delivery.
Don't understand why there is discussion here and on the other board that Favipiravir was speculatively quite prevalent in the Russian sites for the Phase 2.
Did they formulate Favipiravir late last year or early this year to an iv form and hence the minimal 2 month delay for the B+SOC trial??
Anyone see anything about Favipiravir on the European clinical trial site being delivered intravenously??
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Understanding the Investor Landscape The landscape of investor rights is evolving, and in the case of iLearningEngines, Inc., investors find themselves at a significant crossroads. The company, which trades on NASDAQ under the ticker AILE, is currently facing a class action lawsuit led by a dedicated group of investors and the Schall Law Firm. The Class Action Against...
Continue Reading
EditForce's Groundbreaking Research on Myotonic Dystrophy EditForce, Inc. has announced a pivotal breakthrough in the treatment of Myotonic Dystrophy Type 1, significantly enhancing the future of therapeutic options for this challenging condition. The research highlights the efficacy of their innovative PPR platform technology, specifically the CUG-PPR1 protein that...
Continue Reading
The Return of dancemoon MoonRoller and New Layer Brush Mini dancemoon, a pioneer in innovative home cleaning solutions, has officially re-launched its popular flagship product, the dancemoon MoonRoller, alongside the new Layer Brush Mini. This latest offering is now available for purchase globally through the brand's official website and other major e-commerce platforms....
Continue Reading
Carriage Services Announces Earnings Release for Q3 2024 HOUSTON, Carriage Services, Inc. (NYSE: CSV) is set to unveil its third quarter earnings results for 2024. The earnings report is scheduled for release on Wednesday, following the market's closing bell, signaling a vital moment for shareholders and the market at large. Investors are keenly awaiting the insights that...
Continue Reading
Spanish Market Overview The Spanish stock market showed positive momentum recently, with the IBEX 35 index recording a modest gain of 0.19%. This uptick reflects a notable shift in investor sentiment across various sectors, leading to an overall increase in share prices. Leading Sectors Driving Growth The rise in the IBEX 35 was attributed primarily to strong performances...
Continue Reading
